78 related articles for article (PubMed ID: 29937212)
1. Survival gain with re-Op/RT for recurred high-grade gliomas depends upon risk groups.
Chun SJ; Park SH; Park CK; Kim JW; Kim TM; Choi SH; Lee ST; Kim IH
Radiother Oncol; 2018 Aug; 128(2):254-259. PubMed ID: 29937212
[TBL] [Abstract][Full Text] [Related]
2. Re-irradiation for recurrent high-grade glioma: an analysis of prognostic factors for survival and predictors of radiation necrosis.
Moore-Palhares D; Chen H; Keith J; Wang M; Myrehaug S; Tseng CL; Detsky J; Perry J; Lim-Fat MJ; Heyn C; Maralani P; Lipsman N; Das S; Sahgal A; Soliman H
J Neurooncol; 2023 Jul; 163(3):541-551. PubMed ID: 37256526
[TBL] [Abstract][Full Text] [Related]
3. Re-irradiation of recurrent gliomas: pooled analysis and validation of an established prognostic score-report of the Radiation Oncology Group (ROG) of the German Cancer Consortium (DKTK).
Combs SE; Niyazi M; Adeberg S; Bougatf N; Kaul D; Fleischmann DF; Gruen A; Fokas E; Rödel CM; Eckert F; Paulsen F; Oehlke O; Grosu AL; Seidlitz A; Lattermann A; Krause M; Baumann M; Guberina M; Stuschke M; Budach V; Belka C; Debus J; Kessel KA
Cancer Med; 2018 May; 7(5):1742-1749. PubMed ID: 29573214
[TBL] [Abstract][Full Text] [Related]
4. Low-grade gliomas in older patients: long-term follow-up from Mayo Clinic.
Schomas DA; Laack NN; Brown PD
Cancer; 2009 Sep; 115(17):3969-78. PubMed ID: 19536875
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience.
Matsui JK; Allen PK; Perlow HK; Johnson JM; Paulino AC; McAleer MF; Fouladi M; Grosshans DR; Ghia AJ; Li J; Zaky WT; Chintagumpala MM; Palmer JD; McGovern SL
J Neurooncol; 2023 Jul; 163(3):717-726. PubMed ID: 37440097
[TBL] [Abstract][Full Text] [Related]
6. Validation of Combs prognostic scoring system in Indian recurrent glioma patients treated with re-radiation.
Dutta D; Jose M; Kalavagunta S; Sasidharan A; Nair H; Edappattu AH
Radiat Oncol J; 2024 Mar; 42(1):32-42. PubMed ID: 38549382
[TBL] [Abstract][Full Text] [Related]
7. Re-irradiation with stereotactic radiotherapy for recurrent high-grade glial tumors.
Soykut ED; Odabasi E; Sahin N; Tataroglu H; Baran A; Guney Y
Rep Pract Oncol Radiother; 2023; 28(3):361-369. PubMed ID: 37795399
[TBL] [Abstract][Full Text] [Related]
8. Effects of time to chemoradiation on high-grade gliomas from the Buenos Aires Metropolitan Area.
Prost DM; Merenzon MA; Gómez-Escalante JI; Primavera A; Vargas Benítez M; Gil AS; Marenco PM; Califano MM; Moughty Cueto C; Zaloff Dakoff JM; Colonna M; Mazzón A; Zaninovich RS; De Cristófaro OR
PLoS One; 2021; 16(4):e0249486. PubMed ID: 33798233
[TBL] [Abstract][Full Text] [Related]
9. Reirradiation with radiosurgery or stereotactic fractionated radiotherapy in association with regorafenib in recurrent glioblastoma.
Gregucci F; Di Guglielmo FC; Surgo A; Carbonara R; Laera L; Ciliberti MP; Gentile MA; Calbi R; Caliandro M; Sasso N; Davi' V; Bonaparte I; Fanelli V; Giraldi D; Tortora R; Internò V; Giuliani F; Surico G; Signorelli F; Lombardi G; Fiorentino A
Strahlenther Onkol; 2023 Nov; ():. PubMed ID: 37987802
[TBL] [Abstract][Full Text] [Related]
10. Role of nutritional adjuncts in the management of gliomas: A systematic review of literature.
Pahwa B; Leskinen S; Didia E; Huda S; D'Amico RS
Clin Neurol Neurosurg; 2023 Aug; 231():107853. PubMed ID: 37390567
[TBL] [Abstract][Full Text] [Related]
11. Optimizing Recurrent Glioblastoma Salvage Treatment: A Multicenter Study Integrating Genetic Biomarkers From the Korean Radiation Oncology Group (21-02).
Kim D; Lee JH; Kim N; Lim DH; Song JH; Suh CO; Wee CW; Kim IA
Neurosurgery; 2024 Mar; ():. PubMed ID: 38511935
[TBL] [Abstract][Full Text] [Related]
12. Additive Value of MR Simulation Prior to Chemoradiation in Evaluating Treatment Response and Pseudoprogression in High-Grade Gliomas.
Yadav D; Upadhyay R; Kumar VA; Chen MM; Johnson JM; Langshaw H; Curl BJ; Farhat M; Talpur W; Beckham TH; Yeboa DN; Swanson TA; Ghia AJ; Li J; Chung C
Pract Radiat Oncol; 2024 Apr; ():. PubMed ID: 38685448
[TBL] [Abstract][Full Text] [Related]
13. Management and treatment recommendations for World Health Organization Grade III and IV gliomas.
Altwairgi AK; Raja S; Manzoor M; Aldandan S; Alsaeed E; Balbaid A; Alhussain H; Orz Y; Lary A; Alsharm AA
Int J Health Sci (Qassim); 2017; 11(3):54-62. PubMed ID: 28936153
[TBL] [Abstract][Full Text] [Related]
14. High-Grade Glioma Recurrence Is Delayed in Hispanic Patients despite Severe Social Vulnerability: A Retrospective Cohort Study.
Reynolds JA; Pecorari IL; Ledet A; Agarwal V
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672661
[TBL] [Abstract][Full Text] [Related]
15. A Comparative Retrospective Survival Analysis Study of Brain Tumor Patients in Age Less Than or Equal to 50 Years versus More Than 50 Years of Age.
Kesarwani R; Singh A; Aqueel M; Singh V; Prakash G
Asian J Neurosurg; 2023 Dec; 18(4):777-781. PubMed ID: 38161610
[No Abstract] [Full Text] [Related]
16. Incidence and extent of disease progression on MRI between surgery and initiation of radiotherapy in glioblastoma patients.
Kraus RD; Weil CR; Frances Su FC; Cannon DM; Burt LM; Mendez JS
Neurooncol Pract; 2022 Oct; 9(5):380-389. PubMed ID: 36134015
[TBL] [Abstract][Full Text] [Related]
17. Clinical analysis of the efficacy of radiation therapy for primary high-grade gliomas guided by biological rhythms.
Niu Z; Yang Z; Sun S; Zeng Z; Han Q; Wu L; Bai J; Li H; Xia H
Transl Oncol; 2024 Jul; 45():101973. PubMed ID: 38705052
[TBL] [Abstract][Full Text] [Related]
18. INDIGO: Example of inappropriate crossover and why PFS cannot be the primary outcome in gliomas.
Zugman M; Haslam A; Prasad V
J Cancer Policy; 2024 Jun; 40():100476. PubMed ID: 38588795
[No Abstract] [Full Text] [Related]
19. Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers.
Straube C; Combs SE; Bernhardt D; Gempt J; Meyer B; Zimmer C; Schmidt-Graf F; Vajkoczy P; Grün A; Ehret F; Zips D; Kaul D
J Neurooncol; 2024 May; 168(1):49-56. PubMed ID: 38520571
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
